|Bid||179.91 x 100|
|Ask||179.95 x 100|
|Day's Range||179.16 - 180.55|
|52 Week Range||133.64 - 184.21|
|PE Ratio (TTM)||17.09|
|Dividend & Yield||4.60 (2.57%)|
|1y Target Est||N/A|
While Amgen, Inc.'s (AMGN) growth drugs like Prolia & Xgeva might continue to do well. Biosimilar competition and slowdown in sales of mature products can put pressure on sales growth.
Amgen, Inc, Wal-Mart Stores, and Johnson & Johnson could provide safe havens during the next market crash.
A biotech breakout may be fueled by positive medical data and earnings